Viewing Study NCT06994312

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-03-08 @ 1:58 AM
Study NCT ID: NCT06994312
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-29
First Post: 2025-04-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration
Sponsor: The First Hospital of Jilin University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sepsis-induced Coagulopathy (SIC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Single-Center, Prospective, Randomized Controlled Trial View
None sepsis-induced coagulopathy (SIC) View
None Nafamostat Mesylate View
None Prognosis View
None Hemofiltration View